Skip to content
← Back to this collection

PUBLICATIONS · 37199022

Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2023 Aug
First author
Streby KA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Streby KA
      type
      Author
    2. name
      Parisi MT
      type
      Author
    3. name
      Shulkin BL
      type
      Author
    4. name
      LaBarre B
      type
      Author
    5. name
      Bagatell R
      type
      Author
    6. name
      Diller L
      type
      Author
    7. name
      Grupp SA
      type
      Author
    8. name
      Matthay KK
      type
      Author
    9. name
      Voss SD
      type
      Author
    10. name
      Yu AL
      type
      Author
    11. name
      London WB
      type
      Author
    12. name
      Park JR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Streby KA
      type
      Author
    2. name
      Parisi MT
      type
      Author
    3. name
      Shulkin BL
      type
      Author
    4. name
      LaBarre B
      type
      Author
    5. name
      Bagatell R
      type
      Author
    6. name
      Diller L
      type
      Author
    7. name
      Grupp SA
      type
      Author
    8. name
      Matthay KK
      type
      Author
    9. name
      Voss SD
      type
      Author
    10. name
      Yu AL
      type
      Author
    11. name
      London WB
      type
      Author
    12. name
      Park JR
      type
      Author
    bibliography ids
    1. nci-bib-37881610146bab52c2e31ac1
    book metadata
    content sha256
    b06c1acce8bcc7a31dc22e75dea686b9e6024950bfeca29c0b98fc4403a8b9ea
    document type
    citation
    dois
    1. 10.1002/pbc.30418
    electronic publication date
    display
    2023 May 18
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37199022
    immutable id
    pubmed:37199022@b06c1acce8bcc7a31dc22e75dea686b9e6024950bfeca29c0b98fc4403a8b9ea
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    8
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e30418
    volume
    70
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37199022
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      0dbcaf01533a3efa67bcf4a02c4599740d3d78aa37d0113c15bcd99c880e1249
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Aug
      precision
      month
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37199022/
      title
      Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice